A case report describes a 25-year-old woman at 37 +6 weeks of gestation with persistent high fever after induced labor for intrauterine fetal death, in whom AI-assisted review of immune profiling pointed to Listeria monocytogenes after other detected organisms led treatment astray. In the report, a marked rise in IFN-γ and IL-10 plus activated CD8+ T cells prompted a presumptive diagnosis of listeriosis; after switching to ampicillin and gentamicin, her fever rapidly resolved and she recovered.

Why It Matters To Your Practice

• Pregnancy-associated listeriosis is rare, life-threatening, and often presents with nonspecific symptoms, so diagnosis can be delayed.

• This case shows how host immune profiling plus AI support may help when cultures or metagenomic testing identify organisms that do not fit the clinical picture.

• For clinicians using AI in practice, the value here was not automation alone but pattern recognition that redirected therapy in a high-stakes Bacterial infection.

Clinical Implications

• In a febrile pregnant or peripartum patient with poor response to targeted therapy, reconsider whether detected microbes are true pathogens, bystanders, or contaminants.

• An immune pattern featuring elevated IFN-γ, elevated IL-10, and activated CD8+ T cells may support suspicion for Listeria monocytogenes when direct microbiologic confirmation is lacking.

• If clinical suspicion for listeriosis is high, timely treatment with ampicillin plus gentamicin may be appropriate while diagnostic uncertainty is being resolved.

Insights

• External blood culture suggested Staphylococcus capitis, and reproductive tract mNGS detected Ureaplasma urealyticum, but intensified treatment against those findings did not help.

• The AI-assisted step appears to have functioned as a decision-support tool that integrated immune data with the overall presentation rather than replacing clinician judgment.

• This is a single-patient case report, so it is hypothesis-generating and does not establish validated diagnostic performance for any AI model or immune signature.

The Bottom Line

• When standard microbiology is inconclusive or misleading, AI paired with host-response data may help clinicians identify rare infections and choose more effective therapy.

• For practice, the takeaway is to view AI as an adjunct for difficult diagnostic crossroads, especially when the syndrome and the lab results do not match.